Mesa Laboratories (MLAB) 87.50 $MLAB
Mesa Labs reports addition of BGI's assets to its existing product line upon closing
M2 - Wed Apr 16, 3:02AM CDT
Healthcare products company Mesa Laboratories (NasdaqGS:MLAB) said on Monday that it has acquired substantially all of the assets and certain liabilities of BGI Instruments and BGI (collectively BGI), both located in Waltham, Massachusetts for a cash consideration of USD9.9m, subject to a working capital adjustment.
Mesa Labs Acquires the BGI Instruments Business
GlobeNewswire - Tue Apr 15, 8:28AM CDT
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company"
today announced the closing of the acquisition of substantially all (other than cash or accounts receivable) of the assets and certain liabilities of BGI Instruments, Inc. and BGI, Inc. (collectively "BGI", both located in Waltham, MA.
13.3% Return Seen to Date on SmarTrend Mesa Laboratories Call (MLAB)
Comtex SmarTrend(R) - Mon Apr 14, 9:22AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 4 months, Mesa Laboratories has returned 13.34% as of today's recent price of $87.16.
Mesa Labs acquires its French distributor Amilabo SAS
M2 - Mon Apr 07, 9:43AM CDT
Health care company Mesa Laboratories (NasdaqGS:MLAB) reported on Friday the completion of the acquisition of all of the outstanding shares of Amilabo SAS located near Lyon, France.
Mesa Laboratories Up 12.4% Since SmarTrend Uptrend Call (MLAB)
Comtex SmarTrend(R) - Fri Apr 04, 4:52PM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 12.43% as of today's recent price of $86.46.
Mesa Labs Acquires Its French Distributor of Biological Indicators
GlobeNewswire - Fri Apr 04, 12:46PM CDT
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company" today announced the acquisition of Amilabo SAS ("Amilabo", a distributor of the Company's biological indicator (BI) products, located near Lyon, France. In this transaction, Mesa acquired all of the outstanding shares of Amilabo.
Uptrend Call Working As Mesa Laboratories Stock Rises 17.3% (MLAB)
Comtex SmarTrend(R) - Fri Mar 28, 11:15AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 17.27% as of today's recent price of $90.18.
Shares of MLAB Up 20.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 21, 9:55AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 20.78% as of today's recent price of $92.88.
Mesa Laboratories Shares Up 17.9% Since SmarTrend's Buy Recommendation (MLAB)
Comtex SmarTrend(R) - Fri Mar 14, 9:23AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 17.89% as of today's recent price of $90.65.
Nasdaq stocks posting largest percentage decreases
AP - Mon Feb 24, 12:26PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Mesa Labs Reports Record Quarterly Revenues
PR Newswire - Mon Feb 03, 7:00AM CST
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company" today reported record revenues for the third quarter ended December 31, 2013.
Mesa Laboratories Inc's board to pay dividend to holders of record of 28 February 2014
M2 - Mon Feb 03, 6:11AM CST
The board of directors of Mesa Laboratories Inc (NasdaqGS:MLAB), a provider of quality control healthcare instruments, on Friday declared a regular quarterly dividend of USD0.15 per share of the company's common stock.
Mesa Labs Declares Quarterly Dividend
PR Newswire - Fri Jan 31, 4:00PM CST
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company" today announced that its Board of Directors has declared a regular quarterly dividend of $0.15 per share of common stock. The dividend will be payable on March 17, 2014, to stockholders of record at the close of business on February 28, 2014.
Screening for Fun and Profit Is Not Getting Easier
at The Street - Tue Nov 26, 9:45AM CST
What's a value investor to do when the market keeps rising? Here are some possibilities.
Mesa Labs Acquires Two Continuous Monitoring Businesses
PR Newswire - Wed Nov 06, 4:30PM CST
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company" today announced the acquisition of two businesses involved in providing continuous monitoring (or "CM" systems to regulated industries. Mesa acquired substantially all of the assets and certain liabilities of Amega Scientific Corporation, a New Jersey corporation ("Amega" and all of the outstanding shares of common stock of TempSys, Inc., a California corporation ("TempSys".
Mesa Labs Reports 8% Increase in Second Quarter Revenues
PR Newswire - Tue Nov 05, 3:30PM CST
Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, "Mesa" or the "Company" today reported an eight percent increase in revenues for the second quarter ended September 30, 2013.
Mesa Labs reports addition of BGI's assets to its existing product line upon closing
M2 - Wed Apr 16, 3:02AM CDT
Healthcare products company Mesa Laboratories (NasdaqGS:MLAB) said on Monday that it has acquired substantially all of the assets and certain liabilities of BGI Instruments and BGI (collectively BGI), both located in Waltham, Massachusetts for a cash consideration of USD9.9m, subject to a working capital adjustment.
Mesa Labs Acquires the BGI Instruments Business
GlobeNewswire - Tue Apr 15, 8:28AM CDT
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company"
today announced the closing of the acquisition of substantially all (other than cash or accounts receivable) of the assets and certain liabilities of BGI Instruments, Inc. and BGI, Inc. (collectively "BGI", both located in Waltham, MA. 13.3% Return Seen to Date on SmarTrend Mesa Laboratories Call (MLAB)
Comtex SmarTrend(R) - Mon Apr 14, 9:22AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 4 months, Mesa Laboratories has returned 13.34% as of today's recent price of $87.16.
Mesa Labs acquires its French distributor Amilabo SAS
M2 - Mon Apr 07, 9:43AM CDT
Health care company Mesa Laboratories (NasdaqGS:MLAB) reported on Friday the completion of the acquisition of all of the outstanding shares of Amilabo SAS located near Lyon, France.
Mesa Laboratories Up 12.4% Since SmarTrend Uptrend Call (MLAB)
Comtex SmarTrend(R) - Fri Apr 04, 4:52PM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 12.43% as of today's recent price of $86.46.
Mesa Labs Acquires Its French Distributor of Biological Indicators
GlobeNewswire - Fri Apr 04, 12:46PM CDT
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company"
today announced the acquisition of Amilabo SAS ("Amilabo", a distributor of the Company's biological indicator (BI) products, located near Lyon, France. In this transaction, Mesa acquired all of the outstanding shares of Amilabo. Uptrend Call Working As Mesa Laboratories Stock Rises 17.3% (MLAB)
Comtex SmarTrend(R) - Fri Mar 28, 11:15AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 17.27% as of today's recent price of $90.18.
Shares of MLAB Up 20.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 21, 9:55AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 20.78% as of today's recent price of $92.88.
Mesa Laboratories Shares Up 17.9% Since SmarTrend's Buy Recommendation (MLAB)
Comtex SmarTrend(R) - Fri Mar 14, 9:23AM CDT
SmarTrend identified an Uptrend for Mesa Laboratories (NASDAQ:MLAB) on December 24th, 2013 at $76.90. In approximately 3 months, Mesa Laboratories has returned 17.89% as of today's recent price of $90.65.
Nasdaq stocks posting largest percentage decreases
AP - Mon Feb 24, 12:26PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Mesa Labs Reports Record Quarterly Revenues
PR Newswire - Mon Feb 03, 7:00AM CST
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"
today reported record revenues for the third quarter ended December 31, 2013. Mesa Laboratories Inc's board to pay dividend to holders of record of 28 February 2014
M2 - Mon Feb 03, 6:11AM CST
The board of directors of Mesa Laboratories Inc (NasdaqGS:MLAB), a provider of quality control healthcare instruments, on Friday declared a regular quarterly dividend of USD0.15 per share of the company's common stock.
Mesa Labs Declares Quarterly Dividend
PR Newswire - Fri Jan 31, 4:00PM CST
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"
today announced that its Board of Directors has declared a regular quarterly dividend of $0.15 per share of common stock. The dividend will be payable on March 17, 2014, to stockholders of record at the close of business on February 28, 2014. Screening for Fun and Profit Is Not Getting Easier
at The Street - Tue Nov 26, 9:45AM CST
What's a value investor to do when the market keeps rising? Here are some possibilities.
Mesa Labs Acquires Two Continuous Monitoring Businesses
PR Newswire - Wed Nov 06, 4:30PM CST
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"
today announced the acquisition of two businesses involved in providing continuous monitoring (or "CM" systems to regulated industries. Mesa acquired substantially all of the assets and certain liabilities of Amega Scientific Corporation, a New Jersey corporation ("Amega" and all of the outstanding shares of common stock of TempSys, Inc., a California corporation ("TempSys". Mesa Labs Reports 8% Increase in Second Quarter Revenues
PR Newswire - Tue Nov 05, 3:30PM CST
Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, "Mesa" or the "Company"
today reported an eight percent increase in revenues for the second quarter ended September 30, 2013. 
